SOLTF
Price
$5.08
Change
-$0.26 (-4.87%)
Updated
Dec 23 closing price
Capitalization
469.33M
Intraday BUY SELL Signals
SPHDF
Price
$13.35
Change
+$1.08 (+8.80%)
Updated
Nov 13 closing price
Capitalization
218.9M
Intraday BUY SELL Signals
Interact to see
Advertisement

SOLTF vs SPHDF

Header iconSOLTF vs SPHDF Comparison
Open Charts SOLTF vs SPHDFBanner chart's image
Nxera Pharma
Price$5.08
Change-$0.26 (-4.87%)
Volume$2.1K
Capitalization469.33M
Santhera Pharmaceuticals Holdings
Price$13.35
Change+$1.08 (+8.80%)
Volume$200
Capitalization218.9M
SOLTF vs SPHDF Comparison Chart in %
SOLTF
Daily Signal:
Gain/Loss:
SPHDF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
SOLTF vs. SPHDF commentary
Dec 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SOLTF is a Hold and SPHDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 25, 2025
Stock price -- (SOLTF: $5.08 vs. SPHDF: $13.35)
Brand notoriety: SOLTF and SPHDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SOLTF: 386% vs. SPHDF: 72%
Market capitalization -- SOLTF: $469.33M vs. SPHDF: $218.9M
SOLTF [@Biotechnology] is valued at $469.33M. SPHDF’s [@Biotechnology] market capitalization is $218.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SOLTF’s FA Score shows that 0 FA rating(s) are green whileSPHDF’s FA Score has 1 green FA rating(s).

  • SOLTF’s FA Score: 0 green, 5 red.
  • SPHDF’s FA Score: 1 green, 4 red.
According to our system of comparison, SPHDF is a better buy in the long-term than SOLTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SOLTF’s TA Score shows that 4 TA indicator(s) are bullish while SPHDF’s TA Score has 4 bullish TA indicator(s).

  • SOLTF’s TA Score: 4 bullish, 4 bearish.
  • SPHDF’s TA Score: 4 bullish, 0 bearish.
According to our system of comparison, SPHDF is a better buy in the short-term than SOLTF.

Price Growth

SOLTF (@Biotechnology) experienced а -7.98% price change this week, while SPHDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SOLTF($469M) has a higher market cap than SPHDF($219M). SPHDF YTD gains are higher at: 41.720 vs. SOLTF (-17.579).
SOLTFSPHDFSOLTF / SPHDF
Capitalization469M219M214%
EBITDA854MN/A-
Gain YTD-17.57941.720-42%
P/E RatioN/A2.53-
Revenue31.2BN/A-
Total Cash33BN/A-
Total Debt64.7BN/A-
FUNDAMENTALS RATINGS
SOLTF vs SPHDF: Fundamental Ratings
SOLTF
SPHDF
OUTLOOK RATING
1..100
8442
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
8360
P/E GROWTH RATING
1..100
10011
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SPHDF's Valuation (55) in the null industry is somewhat better than the same rating for SOLTF (91). This means that SPHDF’s stock grew somewhat faster than SOLTF’s over the last 12 months.

SPHDF's Profit vs Risk Rating (100) in the null industry is in the same range as SOLTF (100). This means that SPHDF’s stock grew similarly to SOLTF’s over the last 12 months.

SOLTF's SMR Rating (98) in the null industry is in the same range as SPHDF (100). This means that SOLTF’s stock grew similarly to SPHDF’s over the last 12 months.

SPHDF's Price Growth Rating (60) in the null industry is in the same range as SOLTF (83). This means that SPHDF’s stock grew similarly to SOLTF’s over the last 12 months.

SPHDF's P/E Growth Rating (11) in the null industry is significantly better than the same rating for SOLTF (100). This means that SPHDF’s stock grew significantly faster than SOLTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SOLTFSPHDF
RSI
ODDS (%)
Bearish Trend 1 day ago
52%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
52%
Bullish Trend 1 day ago
25%
Momentum
ODDS (%)
Bearish Trend 1 day ago
51%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
44%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
59%
Bullish Trend 1 day ago
12%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
55%
Bullish Trend 1 day ago
12%
Advances
ODDS (%)
Bullish Trend 11 days ago
50%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
65%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
51%
Bullish Trend 1 day ago
16%
View a ticker or compare two or three
Interact to see
Advertisement
SOLTF
Daily Signal:
Gain/Loss:
SPHDF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TMCJX50.330.19
+0.38%
Touchstone Mid Cap C
GGGPX42.400.12
+0.28%
Goldman Sachs Large Cap Equity P
ESECX24.260.05
+0.21%
Eaton Vance Atlanta Capital Sel Eq C
NELAX63.450.08
+0.13%
Nuveen Equity Long/Short A
CISAX8.84N/A
N/A
Copeland International Small Cap A

SOLTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLTF has been loosely correlated with BIESF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLTF jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLTF
1D Price
Change %
SOLTF100%
N/A
BIESF - SOLTF
35%
Loosely correlated
N/A
BSFAF - SOLTF
29%
Poorly correlated
N/A
SPHRF - SOLTF
23%
Poorly correlated
N/A
SLNCF - SOLTF
9%
Poorly correlated
N/A
SPHDF - SOLTF
5%
Poorly correlated
N/A
More

SPHDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPHDF has been loosely correlated with COGT. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPHDF jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHDF
1D Price
Change %
SPHDF100%
N/A
COGT - SPHDF
63%
Loosely correlated
-1.10%
MEOBF - SPHDF
50%
Loosely correlated
N/A
KROS - SPHDF
38%
Loosely correlated
-0.09%
CYTOF - SPHDF
35%
Loosely correlated
+6.25%
XFOR - SPHDF
34%
Loosely correlated
+7.28%
More